Mutation testing of early-onset breast cancer genes BRCA1 and BRCA2

Genetic Testing

Volumn 1, Issue 2, 1997, Pages 75-83

  Neuhausen, Susan L ^a,c   Ostrander, Elaine A ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

BREAST TUMOR; ETHNIC GROUP; FEMALE; FOUNDER EFFECT; GENETIC SCREENING; GENETICS; HUMAN; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS; TUMOR SUPPRESSOR GENE;

AGE OF ONSET; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GENES, TUMOR SUPPRESSOR; GENETIC SCREENING; HUMANS; MUTATION; NEOPLASM PROTEINS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 0031291725     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1997.1.75     Document Type: Article

References (80)

1. ABELIOVICH, D., KADURI, L., LERER, I., WEINBERG, N., AMIR, G., SAGI, M., ZLOTOGORA, J., HECHING, N., and PERETZ, T. (1997). The founder mutations in 185de1AG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet. 60, 505-514.
2. ATHMA, P., RAPPAPORT, R., and SWIFT, M. (1996). Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet. Cytogenet. 92, 130-134.
3. AMERICAN CANCER SOCIETY. (1996). American Cancer Society: Cancer facts and figures. Atlanta, GA.
4. BERRY, D.A., PARMIGIANI, G., SANCHEZ, J., SCHILDKRAUT, J., and WINER, E. (1997). Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J. Natl. Can. Inst. 89(3), 227-238.
5. BISHOP, D.T., and HOPPER, J. (1997). AT-tributable risks? Nature Genet. 15, 226.
6. BOERRESEN, A.L., ANDERSEN, T.I., GARBER, J., BARBIER-PIRAUX, N., THORLACIUS, S., EYFJORD, J., OTTESTAD, L., SMITH-SORENSEN, B., HOVIG, E., MALKIN, D., and FRIEND, S.H. (1992). Screening for germ line TP53 mutations in breast cancer patients. Cancer Res. 52, 3234-3236.
7. BOERRESEN, A-L., HOVIG, E., SMITH-SORENSEN, B., MALKIN, D., LYSTAD, S., ANDERSEN, T.I., NESLAND, J.M., ISSELBACHER, K.J., and FRIEND, S.H. (1991). Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. PNAS 88, 8405-8409.
8. BRINTON, L.A., HOOVER, R., and FRAUMENI, J.F. (1982). Interaction of familial and hormonal risk factors for breast cancer. JNCI 69, 817-822.
9. CALIGO, M.A., GHIMENTI, C., GIOVANNA, C., RICCI, S., BRUNETTI, I., MARCHETTI, V., OLSEN, R., NEUHAUSEN, S., SHATTUCK-EIDENS, D., CONTE, P.F., SKOLNICK, M.H., BEVILACQUA, G. (1996). BRCA1 germline mutational spectrum in Italian families from Tuscany: A high frequency of novel mutations. Oncogene 13, 1483-1488.
10. CANNON-ALBRIGHT, L.A., BISHOP, T., GOLDGAR, D.E., and SKOLNICK, M.H. (1991). Genetic predisposition to cancer. In Important Advances in Oncology, V.T. DeVita, Jr., S. Hellman, and S.A. Rosenberg, eds. (J.B. Lippincott Co. Philadelphia, PA) pp. 39-55.
11. CLAUS, E.B., RISCH, N.J., and THOMPSON, W.D. (1990). Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol. 131, 961-972.
12. CLAUS, E.B., RISCH, N., and THOMPSON, W.D. (1991). Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 48, 232-241.
13. CLAUS, E.B., SCHILDKRAUT, J.M., THOMPSON, W.D., and RISCH, N.J. (1996). The genetic attributable risk of breast and ovarian cancer. Cancer 77, 2318-2324.
14. COUCH, F.J., DESHANO, M.L., BLACKWOOD, M.A., CALZONE, K., STOPPER, J., CAMPEAU, L., GANGULY, A., REBBECK, T., and WEBER, B.L. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336, 1409-1415.
15. COUCH, F.J., FARID, L.M., DESHANO, M.L., TAVTIGIAN, S.V., CALZONE, K., CAMPEAU, L., PENG, Y., BOGDEN, B., CHEN, Q., NEUHAUSEN, S., SHATTUCK-EIDENS, D., GODWIN, A.K., DALY, M., RADFORD, D.M., SEDLACEK, S., ROMMENS, J., SIMARD, J., GARBER, J., MERAJVER, S., and WEBER, B.L. (1996). BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet. 13, 123-125.
16. COUCH, F.J., WEBER, B.L., and BREAST CANCER INFORMATION CORE. (1996). Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum. Mut. 8, 8-18.
17. EASTON, D.F., BISHOP, D.T., FORD, D., CROCKFORD, G.P., and BREAST CANCER LINKAGE CONSORTIUM. (1993). Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am. J. Hum. Genet. 5(4):678-701.
18. EASTON, D., FORD, D., BISHOP, T., and BREAST CANCER LINKAGE CONSORTIUM. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am. J. Hum. Genet. 56, 265-271.
19. EASTON, D.F., STEELE, L., FIELDS, P., ORMISTON, W., AVERILL, D., DALY, P.A., McMANUS, NEUHAUSEN, S.L., FORD, D., WOOSTER, CANNON-ALBRIGHT, L.A., STRATTON, M.R., and GOLDGAR, D.E. (1997). Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am. J. Hum. Genet. 61, 120-128.
20. FITZGERALD, M.G., BEAN, J.M., HEDGE, S.R., UNSAL, H., MACDONALD, D.J., HARKIN, D.P., FINKELSTEIN, D.M., ISSELBACHER, K.J., and HABER, D.A. (1997). Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet. 15, 307-310.
21. FITZGERALD, M.G., MACDONALD, D.J., KRAINER, M., HOOVER, I., O'NEIL, E., UNSAL, H., SILVA-ARRIETO, D., FINKELSTEIN, D.M., BEER-ROMERO, P., ENGLERT, C., SGROI, D.C., SMITH, B.L., YOUNGER, J.W., GARBER, J.E., DUDA, R.B., MAYZEL, K.A., ISSELBACHER, K.J., FRIEND, S.H., and HABER, D.A. (1996). Incidence of BRCA1 germline mutations in early onset breast cancer. N. Engl. J. Med. 334, 143-149.
22. FORD, D., EASTON, D.F., BISHOP, D.T., NAROD, S.A., GOLDGAR, D.E., and BREAST CANCER LINKAGE CONSORTIUM. (1994). Risks of cancer in BRCA1-mutation carriers. Lancet 343, 692-695.
23. FORD, D., EASTON, D.F., and PETO, J. (1995). Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet. 57, 1457-1462.
24. FRIEDMAN, L.S., OSTERMEYER, E.A., SZABO, C.I., DOWD, P., LYNCH, E.D., ROWELL, S.E., and KING, M-C. (1994). Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet. 8, 399-404.
25. GANGULY, A., ROCK, M.J., and PROCKOP, D.J. (1993). Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. PNAS 90, 10325-10329.
26. GAO, Q., NEUHAUSEN, S., CUMMINGS, S., LUCE, M., and OLOPADE, O. (1997). Recurrent germline BRCA1 mutations in extended African American families with early-onset breast cancer. AJHG 60, 1233-1236.
27. GAYTHER, S.A., HARRINGTON, P., RUSSELL, P., KHARKEVICH, G., GARKAVTSEVA, R.F., PONDER, B.A., and UKCCCR FAMILIAL OVARIAN CANCER STUDY GROUP. (1996). Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am. J. Hum. Genet. 58, 451-456.
28. GAYTHER, S.A., HARRINGTON, P., RUSSELL, P., KHARKEVICH, G., GARKAVTSEVA, R.F., and PONDER, B.A. (1997a). Frequently occuring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am. J. Hum. Genet. 60, (5)1239-1242.
29. GAYTHER, S.A., MANGION, J., RUSSELL, P., SEAL, S., BARFOOT, R., PONDER, B.A., STRATTON, M.R., and EASTON, D. (1997b). Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genet. 15, 103-105.
30. GAYTHER, S.A., WARREN, W., MAZOYER, S., RUSSELL, P.A., HARRINGTON, P.A., CHIANO, M., SEAL, S., HAMOUDI, R., VAN RENSBURG, E.J., DUNNING, A.M., LOVE, R., EVANS, G., EASTON, D., CLAYTON, D., STRATTON, M.R., and PONDER, A.J. (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet. 11, 428-433.
31. GOGGINS, M., SCHUTTE, M., LU, J., MOSKALUK, C.A., WEINSTEIN, C.L., PETERSEN, G.M., YEO, C.J., JACKSON, C.E., LYNCH, H.T., HRUBAN, R.H., and KERN, S.E. (1996). Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56, 5360-5354.
32. HACIA, J.C., BRODY, L.C., CHEE, M.C., FODOR, S.P., and COLLINS, F.S. (1996). Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nature Genet. 14, 441-447.
33. HOGERVORST, F.B., CORNELIS, R.S., BOUT, M., VAN VLIET, M., OOSTERWIJK, J.C., OLMER, R., BAKKER, B., KLIJN, J.G., VASEN, H.F., and MEIJERS-HEIJBOER, H. (1995). Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet. 10, 208-212.
34. HUMPHREY, J.S., SALIM, A., ERDOS, M.R., COLLINS, F.S., BRODY, L.C., and KLAUSNER, R.D. (1997). Human BRCA1 inhibits growth in yeast: Potential use in diagnostic testing. Proc. Nat. Acad. Sci. USA 94, 5820-5825.
35. INOUE, R., FUKUTOMI, T., USHIJIMA, T., MATSUMOTO, Y., SUGIMURA, T., NAGAO, M. (1995). Germline mutation of BACA1 in Japanese breast cancer families. Cancer Res. 55, 3521-3524.
36. ISHIOKA, C., SUZUKI, T., FITZGERALD, M., KRAINER, M., SHIMODAIRA, H., SHIMADA, A., NOMIZU, T., ISSELBACHER, K.J., HABER, D., and KANAMARU, R. (1997). Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc. Natl. Acad. Sci. USA 94, 2449-2453.
37. JOHANNSSON, O., OSTERMEYER, E.A., HAKANSSON, S., FRIEDMAN, L.S., JOHANSSON, U., SELLBERG, G., BRONDUM-NIELSEN, K., SELE, V., OLSSON, H., KING, M.C., BORG, A. (1996). Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am. J. Hum. Genet. 58, 441-450.
38. JORDANOVA, A., KALAYDJIEVA, L., SAVOV, A., CLAUSTRES, M., SCHWARZ, M., ESTIVILL, X., ANGELICHEVA, D., HAWORTH, A., CASALS, T., and KREMENSKY, I. (1997). SSCP analysis: A blind sensitivity trial. Hum. Mutat. 10, 65-70.
39. KOSARY, C.L., RIES, L.A.G., MILLER, B.A., HANKEY, B.F., HARRAS, A., and EDWARDS, B.K. (eds). (1995). SEER Cancer statistics review, 1973-1992. Tables and Graphs, National Cancer Institute. NIH Pub. No. 96-2789. Bethesda, MD.
40. KRAINER, M., SILVA-ARRIETA, S., FITZGERALD, M.G., SHIMADA, A., ISHIOKA, C., KANAMARU, R., MACDONALD, D.J., UNSAL, H., FINKELSTEIN, D.M., BOWCOCK, A., ISSELBACHER, K.J., and HABER, D.A. (1997). Differential contribution of BRCA1 and BRCA2 to early onset breast cancer. N. Engl. J. Med. 336, 1416-1421.
41. LANCASTER, J.M., WOOSTER, R., MANGION, J., PHELAN, C.M., COCHRAN, C., GUMBS, C., SEAL, S., BARFOTT, R., COLLINS, N., BIGNELL, G., PATEL, S., HAMOUDI, R., LARSSON, C., WISEMAN, R.W., BERCHUCK, A., INGLEHART, J.D., MARKS, J.R., ASHWORTH, A., STRATTON, M.R., and GUTREAL, PA. (1996). BRCA2 mutations in primary breast and ovarian cancers. Nature Genet. 13, 238-240.
42. LANGSTON, A.A., MALONE, K.E., THOMPSON, J.D., DALING, J.R., and OSTRANDER, E.A. (1996). BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med. 334, 137-142.
43. LEVY-LAHAD, E., CATANE, R., EISENBERG, S., KAUFMAN, B., KORNREICH, G., LISHINSKY, E., SHOHAT, M., WEBER, B.L., BELLER, U., LAHAD, A., and HALLE, D. (1997). Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am. J. Hum. Genet. 60, 1059-1067.
44. LI, J., YEN, C., LIAW, D., PODSYPANINA, K., BOSE, S., WANG, S.I., PUC, J., MILIARESIS, C., RODGERS, L., MCCOMBIE, R., BIGNER, S.H., GIOVANELLA, B.C., UTMANN, M., TYCKO, B., HIBSHOOSH, H., WIGLER, M.H., and PARSONS, R. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1946.
45. LIAW, D., MARSH, D.J., LI, J., DAHIA, P.L.M., WANG, S.I., ZHENG, Z., BOSE, S., CALL, K.M., TSOU, H.C., PEACOCKE, M., ENG, C., and PARSONS, R. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16, 64-67.
46. MALKIN, D., LI, F.P., STRONG, L.C., FRAUMENI, J.F., Jr., NELSON, C.E., KIM, D.H., KASSELL, J., GRYKA, M.A., BISCHOFF. F.Z., TAINSKY, M.A., and FRIEND, S.H. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238.
47. MAZOYER, S., DUNNING, A.M., SEROVA, O., DEARDEN, J., PUGET, N., HEALEY, C.S., GAYTHER, S.A., MANGION, J., STRATTON, M.R., LYNCH, H.T., GOLDGAR, D.E., PONDER. B.A.J., and LENOIR, G.M. (1996). A polymorphic stop codon in BRCA2. Nature Genet. 14, 253-254.
48. MIKI, Y., SWENSEN, J., SHATTUCK-EIDENS, D., FUTREAL, P.A., HARSHMAN, K., TAVTIGIAN, S., LIU, Q., COCHRAN, C., BENNETT, L.M., DING, W., BELL, R., ROSENTHAL, J., HUSSEY, C., TRAN, T., MCCLURE, M., FRYE, C., HATTIER, T., PHELPS, R., HAUGEN-STRANO, A., KATCHER, H., YAKUMO, K., GHOLAMI, Z., SHAFFER, D., STONE, S., BAYER, S., WRAY, C., BOGDEN, R., DAYANANTH, P., WARD, J., TONIN, P., NAROD, S., BRISTOW, P.K., NORRIS, F.H., HELVERING, L., MORRISON, P., ROSTECK, P., LAI, M., BARRETT, J.C., LEWIS, C., NEUHAUSEN, S., CANNON-ALBRIGHT, L., GOLDGAR, D., WISEMAN, R., KAMB, A., and SKOLNICK, M.H. (1994). Isolation of a strong candidate for the 17q-linked breast and ovarian cancer susceptibility gene, BRCA1. Science 266, 66-71.
49. MUTO, M.G., CRAMER, D.W., TANGIR, J., BERKOWITZ, R., and MOK, S. (1996). Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res. 56, 1250-1252.
50. NAROD, S.A., FORD, D., DEVILEE, P., BARKADOTTIR, R.B., LUNCH, H.T., SMITH, S.A., PONDER, B.A.J., WEBER, B.L., GARBER, J.E., BIRCH, J.M., CORNELIS, R.S., KELSELL, D.P., SPURR, N.K., SMYTH, E., HATTES, N., SOBOL, H., BIGNON, Y-J., CHANG-CLAUDE, J., HAMANN, U., LINDBLOM, A., BORG, A., PIVER, M.S., GALLION, H.H., STRUEWING, J.P., WHITTEMORE, A., TONIN, P., GOLDGAR, D.E., EASTON, D.F., BREAST CANCER LINKAGE CONSORTIUM. (1995). An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am. J. Hum. Genet. 56, 254-264.
51. NEUHAUSEN, S., GILEWSKI, T., NORTON, L., TRAN, T., MCGUIRE, P., SWENSEN, J., HAMPEL, H., BORGEN, P., BROWN, K., SKOLNICK, M., SHATTUCK-EIDENS, D., JHANWAR, S., GOLDGAR, D., and OFFIT, K. (1996a). Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genet. 13, 126-128.
52. NEUHAUSEN, S.L., MAZOYER, S., FRIEDMAN, L., STRATTON, M., OFFIT, K., COLEGIO, A., TOMLINSON, G., CANNON-ALBRIGHT, L., BISHOP, T., KELSELL, D., WEBER, B., COUCH, F., STRUEWING, J., TONIN, P., DUROCHER, F., NAROD, S., SKOLNICK, M., LENOIR, G., SEROVA, O., PONDER, B., STOPPA-LYONNET, D., EASTON, D., KING, M-C., and GOLDGAR, D.E. (1996b). Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 60 families: Results of an international study. Am. J. Hum. Gen. 58, 271-280.
53. ODDOUX, C., STRUEWING, J.P., CLAYTON, M., BRODY, L.C., NEUHAUSEN, S., KABACK, M., GOLDGAR, D., OSTRER, H., OFFIT, K. (1996). The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genetics 14, 188-190.
54. OFFIT, K., GILEWSKI, T., MCGUIRE, P., SCHLUGER, A., BROWN, K., NEUHAUSEN, S., SKOLNICK, M., NORTON, L., GOLDGAR, D. (1996). Germline BRCA1 185delAG mutations in Jewish women affected by breast cancer. Lancet 347, 1643-1645.
55. ORITA, M., IWAHANA, H., KANAZAWA, H., HAYASHI, K., and SEKIYA, T. (1989). Detection of polymorphisms of human DNA by gel electropheresis as single strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA 86, 2766-2770.
56. OTTMAN, R., PIKE, M.C., KING, M-C., CASAGRANDE, J.T., and HENDERSON, B.E. (1986). Familial breast cancer in a population-based series. Am. J. Epidemiol. 123, 15-21.
57. OZCELIK, H., SCHMOCKER, B., DINICOLA, N., SHI, X-H., LANGER, B., MOORE, M., TAYLOR, B.R., NAROD, S.A., DARLINGTON, G., ANDRULIS, I.L., GALLINGER, S., and REDSTON, M. (1997). Germline BRCA2 6174 delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nature Genetics 16, 17-18.
58. PLUMMER, S.J., ANTON-CULVER, H., WEBSTER, L., NOBLE, B., OIAO, S., KENNEDY, A., BELINSON, J., and CASEY, G. (1995). Detection of BRCA1 mutations by the protein truncation test. Hum. Mol. Genet. 4, 1989-1991.
59. PUGET, N., TORCHARD, D., SEROVA-SINILNIKOVA, O.M., LYNCH, H.T., FEUNTEUN, J., LENOIR, G.M., and MAZOYER, S. (1997). A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res. 57, 828-831.
60. ROEST, P.A., ROBERTS, R.G., SUGINO, S., VAN OMMEN, G.J., and DEN DUNNEN, J.T. (1993). Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum. Mol. Genet. 2, 1719-1721.
61. SATTIN, R.W., RUBIN, G.L., WEBSTER, L.A., HUEZO, C.M., WINGO, P.A., ORY, H.W., and LAYDE, P.M. (1985). The cancer and steroid hormone study: Family history and the risk of breast cancer. JAMA 253, 1908-1913.
62. SAVITSKY, K., BAR-SHIRA, A., GILAD, S., ROTMAN, G., ZIV, Y., VANAGAITE, L., TAGLE, D.A., SMITH, S., UZIEL, T., SFEZ, S., ASHKENAZI, M., PECKER, I., FRYDMAN, M., HARNIK, R., PATANJALI, S.R., SIMMONS, A., CLINES, G.A., SARTIEL, A., GATTI, R.A., CHESSA, L., SANAL, O., LAVIN, M.F., JASPERS, N.G.J., TAYLOR, A.R., ARLETT, C.F., MIKI, T., WEISSMAN, S.M., LOVETT, M., COLLINS, F.S., and SHILOH, Y. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753.
63. SCHUBERT, E.L., LEE, M.K., MEFFORD, H.C., ARGONZA, R.H., MORROW, J.E., HULL, J., DANN, J.L., and KING, M.C. (1997). BRCA2 in American families with four or more cases of breast or ovarian cancer: Recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am. J. Hum. Genet. 60, 1031-1040.
64. SEROVA, O.M., MAZOYER, S., PUGET, N., DUBOIS, V., TONIN, P., SHUGART, Y.Y., GOLDGAR, D., NAROLD, S.A., LYNCH, H.T., and LENOIR, G.M. (1997). Mutations in BRCA1 and BRCA2 in breast cancer families: Are there more breast cancer-susceptibility genes? Am. J. Hum. Genet. 60, 486-495.
65. SIGURDSSON, S., THORLACIUS, S., TOMASSON, J., TRYGGVADOTTIR, L., BENEDIKTSDOTTIR, K., EYFJORD, J.E., JONSSON, E. (1997). BRCA2 mutation in Icelandic prostate cancer patients. J. Mol. Med. 75, 758-761.
66. SIMARD, J., TONIN, P., DUROCHER, F., MORGAN, K., ROMMENS, J., GINGRAS, S., SAMSON, C., LEBLANC, J.F., BELANGER, C., DION, F., LIU, Q., SKOLNICK, M., GOLDGAR, D., SHATTUCK-EIDENS, D., LABRIE, F., and NAROLD, S.A. (1994). Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genetics 8, 392-398.
67. STECK, P.A., PERSHOUSE, M.A., JASSER, S.A., YUNG, W.K.A., LIN, H., LIGON, A.H., LANGFORD, L.A., BAUMGARD, M.L., HATTIER, T., DAVIS, T., FRYE, C., HU, R., SWEDLUND, B., TENG, D.H.F., and TAVTITIAN, S.V. (1997). Identification of a candidate tumour suppressor gene, MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics 15, 356-262.
68. STOPPA-LYONNET, D., FRICKER, J.P., ESSIOUX, L., PAGES, S., LIMACHER, J.M., SOBOL, H., LAURENT-PUIG, P., and THOMAS, G. (1996). Segregation of two BRCA1 mutations in a single family. Am. J. Hum. Genet. 59, 479-481.
69. STRUEWING, J.P., ABELIOVICH, D., PERETZ, T., AVISHAI, N., KABACK, M.M., COLLINS, F.S., and BRODY, L.C. (1995). The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genetics 11, 198-200.
70. STRUEWING, J.P., HARTGE, P., WACHOLDER, S., BAKER, S.M., BERLIN, M., MCADAMS, M., TIMMERMAN, M.M., BRODY, L.C., and TUCKER, M.A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med. 336, 1401-1408.
71. SWENSEN, J., HOFFMAN, M., SKOLNICK, M.H., and NEUHAUSEN, S.L. (1997). Identification of a 14-kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum. Mol. Genet. 9, 1513-1517.
72. SZABO, C.I., and KING, M.C. (1995). Inherited breast and ovarian cancer. Hum. Mol. Genet. 4, 1811-1817.
73. SZABO, D.I., and KING, M.C. (1997). Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60, 1013-1020.
74. THOMPSON, M.E., JENSEN, R.A., OBERMILLER, P.S., PAGE, D.L., and HOLT, J.T. (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9, 444-450.
75. THORLACIUS, S., OLAFSDOTTIR, G., TRYGGVADOTTIR, L., NEUHAUSEN, S., JONASSON, J.G., TAVTIGIAN, S.V., TULINIUS, H., OGMUNDSDOTTIR, and EYFJORD, J.E. (1996). A single mutation in the BRCA2 gene in male and female breast cancer families with varied cancer phenotypes. Nature Genet. 13, 117-119.
76. THORLACIUS, S., SIGURDSSON, S., BJARNADOTTIR, H., OLAFSDOTTIR, G., JONASSON, J.G., TRYGGVADOTTIR, L., TULINIUS, H., EYFJORD, J.E. (1997). Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet. 60, 1079-1084.
77. TONIN, P., SEROVA, O., LENOIR, G., LYNCH, H., DUROCHER, F., SIMARD, J., MORGAN, K., and NAROD, S. (1995). BRCA1 in Ashkenazi Jewish women. Am. J. Hum. Genet. 57, 189.
78. TONIN, P., WEBER, B., OFFIT, K., COUCH, F., REBBECK, T., NEUHAUSEN, S., GODWIN, A., DALY, M., WAGNER, J., BERMAN, D., GRANA, G., FOX, E., KANE, M., KOLODNER, R.D., HABER, D., STRUEWING, J., WARNER, E., ROSEN, B., FOULKES, W., LERMAN, C., PESHKIN, B., SEROVA, O., LYNCH, H.T., LENOIR, G.M., NAROD, S.A., and GARBER, J.E. (1996). A high frequency of BRCA1 and BRCA2 mutations in 222 Ashkenazi Jewish breast cancer families. Nature Med. 2, 1179-1183.
79. WHITTEMORE, A.S., GONG, G., and ITNYRE, J. (1997). Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer. Am. J. Hum. Genet. 60, 496-504.
80. WOOSTER, R., BIGNELL, G., LANCASTER, J., SWIFT, S., SEAL, S., MANGLON, J., COLLINS, N., GREGORY, S., GUMBS, C., MICKLEM, G., BARFOOT, R., HANOUDI, R., PATEL, S., RICE, C., BIGGS, P., HASHIM, Y., SMITH, A., CONNOR, F., ARASON, A., GUDMUNDSSON, J., FICENEC, D., KELSEL, D., FORD, D., TONIN, P., BISHOP, D.T., SPURR, N.K., PONDER, B.A.J., EELES, R., PETO, J., DEVILEE, P., CORNELISSE, C., LYNCH, H., NAROD, S., OENOIR, G., EGLISSON, V., BARKADOTTLR, R.B., EASTON, D.F., BENTLEY, D.R., FUTREAL, P.A., ASHWORTH, A., and STRATTON, M.R. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.